

In November 2025, commuters at Manhattan's Broadway-Lafayette subway station walked past posters of smiling toddlers above three words: "Have your best baby." Others read "Have a smarter baby" and "Have a taller baby." The ads came from Nucleus Genomics, a startup that says it can score IVF embryos for roughly 2,000 traits and disease risks so parents can choose the one they like best.
This is polygenic embryo screening. It has moved quickly from the fringe of fertility medicine to the subway wall. MIT Technology Review even named embryo scoring one of its "10 Breakthrough Technologies" of 2026.
For Christians, the question is not only whether the science works. It is what kind of people we become when we start to shop for our children. This article looks at what the technology claims to do, why it grows straight out of the problems already present in IVF, how it echoes the eugenics movement, and what it may do to the hearts of parents.
Polygenic embryo screening (often called PGT-P) ranks IVF embryos by their predicted odds of complex diseases and traits. Older embryo tests looked for a single faulty gene, such as the one behind cystic fibrosis. PGT-P adds up thousands of small genetic signals into a "polygenic score" for conditions like diabetes and heart disease, and, increasingly, for height and intelligence.
The process starts with IVF. Doctors fertilize several eggs in a lab, grow the embryos for about five days, and remove a few cells from each for DNA testing. A company then hands parents a report card for every embryo. The parents pick which one to implant. The rest are frozen, donated to research, or discarded.
The market has grown fast:
These services are now .. In the U.S., unlike the UK, selecting embryos for predicted IQ is legal.
The leading medical genetics bodies have rejected the practice:
• The American College of Medical Genetics and Genomics found "insufficient evidence of clinical utility" and said PGT-P should not be offered as a clinical service.
• The European Society of Human Genetics called it "an unproven, unethical practice" and warned it "could easily lead to discrimination and the stigmatisation of certain conditions."
The research explains why. A 2019 study in Cell found that choosing the top-scoring of 10 embryos would gain, on average, about 2.5 IQ points or 2.5 centimeters of height, with wide uncertainty. Many couples never have 10 viable embryos to choose from. A 2021 paper in the New England Journal of Medicine added that selecting for educational attainment raised the predicted risk of bipolar disorder, because the genetic signals overlap. Bioethicist Arthur Caplan and philosopher James Tabery argued in Scientific American that genetic "optimization" is more hype than science.
In other words, parents are paying thousands of dollars for probabilities, not promises. That gap between what is sold and what is delivered matters later, when we turn to the hearts of parents.
Polygenic screening did not invent the ethical problems of IVF. It inherits them and sharpens them. IVF is now common: U.S. clinics reported 449,772 treatment cycles and 100,158 babies born in 2024, the first year above 100,000.
Every one of those babies is a gift. The concern lies in the process, which routinely creates more embryos than will ever be carried to birth. One study estimated 1.4 million frozen embryos in U.S. storage, and researchers believe 5 to 7 percent are abandoned, as high as 18 percent at some clinics. If human life begins at conception, as Scripture suggests (Psalm 139:13-16; Jeremiah 1:5), those are not spare materials. They are our smallest neighbors.
IVF already asks parents to treat early human lives as a set of options. Clinics grade embryos by appearance and test them for chromosome problems, then choose which to transfer. Polygenic screening simply adds more columns to the spreadsheet. The embryo once ranked by its odds of implanting is now ranked by its odds of being tall, healthy, or bright.
That shift also changes the incentives. A larger pool of embryos yields a slightly better "top" pick, so the technology rewards creating more embryos and leaving more behind. Heliospect's offer to rank 100 embryos shows where this leads. Caplan and Tabery warn that parents "might avoid perfectly healthy embryos, scared of implanting ones that don't appear to be sufficiently optimized." The question moves from "Will we have a child?" to "Which child will we keep?"
The word "eugenics" was coined in 1883 by Francis Galton, a cousin of Charles Darwin, for the study of how to "improve or impair the racial qualities of future generations."15 The idea rested on a belief that humans could be perfected through selective breeding.
America put that belief into law. In Buck v. Bell (1927), the Supreme Court upheld the forced sterilization of Carrie Buck, with Justice Oliver Wendell Holmes Jr. writing, "Three generations of imbeciles are enough." The ruling gave legal cover to sterilize more than 60,000 Americans in more than 30 states. Nazi Germany carried the same logic further, sterilizing at least 400,000 people and killing about 75,200 deemed "unworthy of life."
Today's embryo screening differs in one way that matters: no government forces it. The choice belongs to parents. Its supporters call this "liberal eugenics." Jonathan Anomaly, a philosopher who now works at Herasight, once titled a paper "Defending Eugenics" and defined eugenics as "any attempt to harness the power of reproduction to produce people with traits that enable them to thrive." Even the National Human Genome Research Institute cautions that eugenic ideas persist in today's debates over genomic screening.
But moving the decision from the state to the parent does not change the core question. Both systems sort human beings by predicted worth, then decide who gets to be born. Old eugenics did it through courts and clinics. New eugenics does it through the market, one IVF cycle at a time.
Several warning signs are already visible:
Eugenics rarely arrives announcing itself. It arrives as a reasonable choice, offered to people who want the best for their children.
The deepest cost of embryo scoring may not be scientific or social. It may be what it does inside the family. When a child is chosen from a ranked list, the child can quietly become a purchase, and purchases come with expectations.
Harvard philosopher Michael Sandel, writing from a secular starting point, argues that parenthood is "a school for humility." Because "we don't choose the kind of child that we have," he says, parents learn "an openness to the unbidden" that helps them "rein in the impulse to mastery and control." Sandel notes that seeing a child as a gift "does have religious resonance."
Polygenic screening reverses that lesson. The child no longer simply arrives. The child is selected, and the selection carries a predicted height, a predicted IQ, and a price tag that can run from $6,000 to $50,000.
Remember that the predicted benefits are small and uncertain: about 2.5 IQ points on average, with wide margins either way. Many "top-scoring" children will not turn out to be the tallest, healthiest, or brightest. Doctors already worry these tests will create unrealistic parental expectations. Caplan and Tabery describe the result plainly: children "expected to live up to their purchased optimized future."
That gap sets the stage for something like buyer's remorse:
"Did we get what we paid for?" A child who struggles in school or develops the very disease screened against can feel, to a disappointed parent, like a failed product rather than a beloved son or daughter.
"What about the others?" Psychologist Barry Schwartz has shown that "one of the 'costs' of making a selection is losing the opportunities that a different option would have afforded," and that "the greatest maximizers are the least happy with the fruits of their efforts". With embryos, the "other options" are siblings who were never born, and some are still in a freezer.
The burden of a "moral duty." Researchers note the pressure parents may feel to select "the best embryo." IVF patients interviewed in a 2024 study in Reproductive Biomedicine Online worried that risk scores could bring "anxiety and overprotection," adding that it "doesn't necessarily make you happier."
The scores may also change how parents raise the child. A 2023 paper in the American Journal of Bioethics proposed a "nurtured genetics" effect: parents may steer a child toward the book club or the baseball field based on genetic predictions. The authors note that classic research on teacher expectations found an effect worth about 6.45 IQ points, more than twice the 2.5-point gain from embryo selection.
In plain terms, the label may matter more than the genes. A child raised as "the smart one we picked" carries a weight no child should carry. A child who falls short may sense that their parents' love was conditional on a forecast.
Scripture says children are "a heritage from the Lord, offspring a reward from him" (Psalm 127:3). A heritage is received, not ordered. When we grade embryos, we train ourselves to see people as bundles of traits to be optimized, not as image-bearers to be welcomed. Over time, that habit can dull our wonder at God's handiwork, in our children and in everyone else.
The deepest problem with designer selection is not that it might fail. It is that it claims a role that belongs to God alone.
Scripture presents every human being as a personal, deliberate work of God. "For you formed my inward parts; you knitted me together in my mother's womb. I praise you, for I am fearfully and wonderfully made" (Psalm 139:13-14). Before we were born, "your eyes saw my unformed substance; in your book were written, every one of them, the days that were formed for me" (Psalm 139:16).
God's design is also wonderfully particular. No two people, not even identical twins, are the same. Each bears the image of God (Genesis 1:27) in a way no one else will. Even the traits we might never choose belong to His purposes. When Moses protested his weakness, God answered, "Who has made man's mouth? Who makes him mute, or deaf, or seeing, or blind? Is it not I, the Lord?" (Exodus 4:11). When the disciples asked whose sin caused a man's blindness, Jesus said it was "that the works of God might be displayed in him" (John 9:3).
A polygenic score sees a child as a list of probabilities. God sees a person He has known by name from before the foundation of the world.
Job suffered more than most of us ever will, and he demanded that God explain Himself. When God finally spoke, He did not hand Job a report. He asked him questions:
"Where were you when I laid the foundation of the earth? Tell me, if you have understanding." (Job 38:4)
Over four chapters (Job 38-41), God walks Job through the cosmos: the stars, the sea, the storehouses of snow, the lion and the raven, the wild donkey and the war horse. Many of His questions touch on life and birth. He describes the sea bursting "from the womb" (38:8). He asks, "Do you know when the mountain goats give birth? Do you observe the calving of the does?" (39:1). He asks, "Who has put wisdom in the inward parts or given understanding to the mind?" (38:36).
That last question lands with special force in an age that claims to rank embryos for intelligence. God's point is not that knowledge is bad. It is that Job, and we, are creatures. We did not design the world, we do not sustain it, and we cannot see the whole of it. Then God presses further: "Will you even put me in the wrong? Will you condemn me that you may be in the right?" (40:8).
Job's response is the right one for us too: "I know that you can do all things, and that no purpose of yours can be thwarted... I have uttered what I did not understand, things too wonderful for me, which I did not know" (42:2-3).
The oldest temptation in Scripture was the promise that "you will be like God, knowing good and evil" (Genesis 3:5). The builders of Babel wanted to "make a name for ourselves" by reaching the heavens on their own terms (Genesis 11:4). Polygenic selection carries the same impulse in clinical form. It invites parents to decide which kind of person deserves to exist, which traits count as "best," and which embryos are left behind.
That is a judgment only the Creator is fit to make. Isaiah warns: "Woe to him who strives with him who formed him... Does the clay say to him who forms it, 'What are you making?'" (Isaiah 45:9). When we screen embryos for height and IQ, the clay is no longer just questioning the potter. It is trying to take his place at the wheel.
None of this means the longing for a child is wrong. Infertility is a real grief, and couples walking through it deserve compassion, not condemnation. Wanting a healthy child is natural and good. But Scripture calls us to receive children, not to design them, and to trust that the God who answered Job knows far better than any algorithm what each life is for.
Polygenic embryo screening is sold as empowerment: more information, better choices, healthier children. In reality it offers small, uncertain gains at a high moral price. It multiplies the embryos created and left behind, revives the logic of eugenics through the market, and risks turning children from gifts into products.
That is why In Vitro Fertilization is one of the negative screening categories in Inspire Insight. As embryo selection moves from disease screening to IQ and height, investors who want their portfolios to honor the sanctity of life should know which companies profit from creating, ranking, and discarding human embryos.
The God who spoke to Job still holds the foundations of the earth. He still forms each child in secret, and He still makes no mistakes. Our calling is not to improve on His work, but to receive it with gratitude.
"I praise you, for I am fearfully and wonderfully made. Wonderful are your works; my soul knows it very well." (Psalm 139:14)

Bringing ten years of experience as a professor at a Christian college, Chris is deeply rooted in faith-based values. He excels as a faith-based writer, adept at crafting financial curriculum with spiritual depth. In his role, Chris is responsible for sourcing and evaluating reliable sources to accurately screen companies and assign them an Inspire Impact Score. Furthermore, he meticulously curates screening categories to maintain clarity and alignment with Inspire's faith-based mission.